Clinical characteristics and outcomes of older women with breast cancer in Mexico


Por: Cabrera-Galeana P., Soto-Perez-de-Celis E., Reynoso-Noverón N., Villarreal-Garza C., Arce-Salinas C., Matus-Santos J., Ramírez-Ugalde M.T., Alvarado-Miranda A., Meneses-García A., Lara-Medina F., Torres-Dominguez J., Bargalló-Rocha E., Mohar A.

Publicada: 1 ene 2018 Ahead of Print: 1 ene 2018
Resumen:
Introduction: Although the epidemiology of breast cancer in older women has been widely described before, little is known about the clinical characteristics and prognosis of older patients living in developing countries. Here, we studied older women with breast cancer treated at a public cancer center in Mexico City, and compared their outcomes with their younger counterparts. Materials and Methods: We retrospectively analyzed a database of 5488 women treated for breast cancer at a single institution. We compared clinical characteristics, treatment and survival between women aged <65 and =65 years of age. Survival analyses were performed for each molecular subtype. Results: 851 women (15.5%) were =65 years of age, of which 45% presented with Stages III–IV disease. Compared with their younger counterparts, older women had lower grade disease, a larger proportion of hormone receptor positive tumors, and were less likely to receive both chemotherapy and radiotherapy. At 5 years, no differences in both disease free and overall survival were found between younger and older women in a multivariate model including stage, grade, tumor subtype and treatment received. Conclusions: In contrast with reports from high-income countries, older women with breast cancer in developing nations present with more advanced disease requiring more aggressive treatment. Strategies aimed at earlier detection, improved access to care, and downstaging among older adults are greatly needed in Mexico and in the rest of the developing world. © 2018

Filiaciones:
Cabrera-Galeana P.:
 Departamento de Tumores Mamarios, Instituto Nacional de Cancerología, Mexico City, Mexico

 Instituto Nacional de Cancerología, Mexico City, Mexico

Soto-Perez-de-Celis E.:
 Departamento de Tumores Mamarios, Instituto Nacional de Cancerología, Mexico City, Mexico

 Department of Geriatrics, Instituto Nacional de Ciencias Médicas y Nutriciõn Salvador Zubirán, Mexico City, Mexico

 Instituto Nacional de Cancerología, Mexico City, Mexico

Reynoso-Noverón N.:
 Departamento de Tumores Mamarios, Instituto Nacional de Cancerología, Mexico City, Mexico

 Instituto Nacional de Cancerología, Mexico City, Mexico

Villarreal-Garza C.:
 Departamento de Tumores Mamarios, Instituto Nacional de Cancerología, Mexico City, Mexico

 Instituto Tecnológico de Monterrey, Monterrey, Mexico

 Instituto Nacional de Cancerología, Mexico City, Mexico

Arce-Salinas C.:
 Departamento de Tumores Mamarios, Instituto Nacional de Cancerología, Mexico City, Mexico

 Instituto Nacional de Cancerología, Mexico City, Mexico

Matus-Santos J.:
 Departamento de Tumores Mamarios, Instituto Nacional de Cancerología, Mexico City, Mexico

 Instituto Nacional de Cancerología, Mexico City, Mexico

Ramírez-Ugalde M.T.:
 Departamento de Tumores Mamarios, Instituto Nacional de Cancerología, Mexico City, Mexico

 Instituto Nacional de Cancerología, Mexico City, Mexico

Alvarado-Miranda A.:
 Departamento de Tumores Mamarios, Instituto Nacional de Cancerología, Mexico City, Mexico

 Instituto Nacional de Cancerología, Mexico City, Mexico

Meneses-García A.:
 Instituto Nacional de Cancerología, Mexico City, Mexico

Lara-Medina F.:
 Departamento de Tumores Mamarios, Instituto Nacional de Cancerología, Mexico City, Mexico

 Instituto Nacional de Cancerología, Mexico City, Mexico

Torres-Dominguez J.:
 Departamento de Tumores Mamarios, Instituto Nacional de Cancerología, Mexico City, Mexico

 Instituto Nacional de Cancerología, Mexico City, Mexico

Bargalló-Rocha E.:
 Departamento de Tumores Mamarios, Instituto Nacional de Cancerología, Mexico City, Mexico

 Instituto Nacional de Cancerología, Mexico City, Mexico

Mohar A.:
 Unidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología e Instituto de Biomédicas, Mexico City, Mexico
ISSN: 18794068
Editorial
Elsevier Ltd, RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, Países Bajos
Tipo de documento: Article
Volumen: 9 Número: 6
Páginas: 620-625
WOS Id: 000448490800012
ID de PubMed: 29691196